Growing strategic competition between China and the West – particularly the United States – will increasingly play out in the biotechnology and pharmaceutical industries, and when coupled with AI’s ...

In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

Overview of Whole Genome Synthesis MarketThe global Whole Genome Synthesis Market is valued at USD 2.41 Billion in 2024 and is projected to reach a value of USD 12.21 Billion by 2035 at a CAGR ...

Both CRSP and NTLA are advancing in vivo gene editing therapies targeting large markets, with financial stability supporting ...

Abstract: Graph machine learning has been extensively studied in both academia and industry. Although booming with a vast number of emerging methods and techniques, most of the literature is built on ...

Abstract: With the development of knowledge graph completion technology, many models have emerged that can predict missing relations in knowledge graphs with high accuracy. However, these relation ...

CRISPR Therapeutics could maintain that momentum thanks to progress with its leading candidates. Spotify Technologies' deep ...

DUBAI, Oct 14 (Reuters) - Chinese e-commerce giant Alibaba's (9988.HK), opens new tab cloud business unit has launched its second data centre in Dubai, it said on Tuesday, nine years after its first, ...